MedPath

A Prospective Study on the Comparison of Postoperative Pain According to the Use of Cocktail Therapy in Laminoplasty

Phase 4
Not yet recruiting
Conditions
Adverse Effects in the Therapeutic Use of Analgesic, Antipyretic and Anti-Inflammatory Drug, Unspecified
Interventions
Drug: Cocktail injection
Registration Number
NCT06113497
Lead Sponsor
Kyunghee University Medical Center
Brief Summary

This study is the first prospective randomized controlled trial to analyze the effects and safety of multimodal cocktail injections after cervical laminoplasty

Detailed Description

This study is the first prospective randomized controlled trial to analyze the effects and safety of multimodal cocktail injections after cervical laminoplasty. Through this study, we anticipate that the potential usefulness of multimodal cocktail analgesic injections in various aspects of spinal surgery will be demonstrated, offering valuable insights and possibilities.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Diagnosed with cervical myelopathy or radiculopathy and scheduled to undergo laminoplasty
  • Recorded preoperative upper limb pain (Visual Analog Scale [- VAS] ), neck pain (VAS), Japanese Orthopaedic Association (JOA) scores, and Neck Disability Index (NDI) scores.
  • Adults aged 20 years and above, but below 80 years capable of articulating their own pain or functional abnormalities
  • Cognitive function at a level that enables them to comprehend and adhere to study procedures
Exclusion Criteria
  • Previous surgical treatment of the cervical spine.
  • Adolescents aged 20 years or below, pregnant individuals, or those with the potential for pregnancy.
  • Hypersensitivity reactions to mixed medications used in Cocktail therapy. (morphine 5 mg, ropiva 150 mg, tamceton 40 mg, epinephrine 1 mg, ketocin 60 mg, jetiam 1 g).
  • Patients who lack the capacity for medical consent or are unable to communicate effectively in a medical context.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Group 2Cocktail injectionThe group that received cocktail therapy injection into the deep fascia and muscular layer during wound closure.
Primary Outcome Measures
NameTimeMethod
Change from Baseline in Pain (VAS/Visual Analog Score)Baseline and Post operation 7 days

A VAS score, also known as a Visual Analog Scale score, is a common method used in healthcare and research to measure subjective or self-reported sensations or experiences, such as pain, anxiety, mood, or other subjective states. It typically consists of a horizontal or vertical line, usually 10 centimeters in length, with anchor points at either end. One end is labeled with the most negative or extreme aspect of the sensation or experience being measured, and the other end is labeled with the most positive or least extreme aspect.

Change from Baseline in function (JOA/Japanese Orthopaedic Association Score) scoreBaseline and Post operation 7 days

The JOA score is often calculated based on a specific set of criteria and is used to help guide treatment decisions and monitor a patient's progress. It provides a standardized way to assess and communicate the clinical status of individuals with cervical myelopathy. The score may range from 0 (severe impairment) to 17 (normal function), with lower scores indicating greater disability.

Change from Baseline in function (NDI/Neck Disability Index score) scoreBaseline and Post operation 7 days

The NDI questionnaire typically consists of ten questions or items, and individuals are asked to rate their level of disability or limitation in various aspects of daily life due to neck pain. The questions cover a range of activities, including personal care, work, sleep, and recreational activities. Each question is scored on a scale from 0 to 5, with 0 indicating no disability and 5 indicating severe disability. The individual's responses to these questions are then totaled to calculate the NDI score, usually expressed as a percentage.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath